{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:49:17Z","timestamp":1761126557695},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mod Rheumatol"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1007\/s10165-008-0037-0","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T15:49:18Z","timestamp":1204300158000},"page":"240-246","source":"Crossref","is-referenced-by-count":17,"title":["Asymptomatic carriage of Pneumocystis jiroveci in elderly patients with rheumatoid arthritis in Japan: a possible association between colonization and development of Pneumocystis jiroveci pneumonia during low-dose MTX therapy"],"prefix":"10.1093","volume":"18","author":[{"given":"Shunsuke","family":"Mori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isamu","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Ichiyasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineharu","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,2,29]]},"reference":[{"key":"37_CR1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jbspin.2006.01.007","volume":"73","author":"S Pavy","year":"2006","unstructured":"Pavy S, Constantin A, Pham T, Gossec L, Maillefert JF, Cantagrel A, et al. Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion. Joint Bone Spine. 2006;73:388\u201395.","journal-title":"Joint Bone Spine."},{"key":"37_CR2","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/ard.2005.044354","volume":"66","author":"B Combe","year":"2007","unstructured":"Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis. 2007;66:34\u201345.","journal-title":"Ann Rheum Dis"},{"key":"37_CR3","first-page":"639","volume":"20","author":"R Buchbinder","year":"1993","unstructured":"Buchbinder R, Hall S, Sambrook PN, Champion GD, Harkness A, Lewis D, et al. Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice. J Rheumatol. 1993;20:639\u201344.","journal-title":"J Rheumatol"},{"key":"37_CR4","first-page":"238","volume":"25","author":"ME Weinblatt","year":"1998","unstructured":"Weinblatt ME, Maier AL, Fraser PA, Coblyn JS. Long-term prospective study of methotrexate in rheumatoid arthritis: conclusion after 132\u00a0months of therapy. J Rheumatol. 1998;25:238\u201342.","journal-title":"J Rheumatol"},{"key":"37_CR5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0889-857X(05)70368-9","volume":"23","author":"KS Kanik","year":"1997","unstructured":"Kanik KS, Cash JM. Does methotrexate increase the risk of infection or malignancy? Rheum Dis Clin North Am. 1997;23:955\u201367.","journal-title":"Rheum Dis Clin North Am"},{"key":"37_CR6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0049-0172(95)80009-3","volume":"24","author":"AM Boerbooms","year":"1995","unstructured":"Boerbooms AM, Kerstens PJ, van Loenhout JW, Mulder J, van de Putte LB. Infections during low-dose methotrexate treatment in rheumatoid arthritis. Semin Arthritis Rheum. 1995;24:411\u201321.","journal-title":"Semin Arthritis Rheum"},{"key":"37_CR7","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1002\/art.10524","volume":"46","author":"MF Doran","year":"2002","unstructured":"Doran MF, Crowson CS, Pond GR, O\u2019Fallon WM, Gabriel SE. Frequency of infection in patients with rheumatoid arthritis compared with controls: a population-based study. Arthritis Rheum. 2002;46:2287\u201393.","journal-title":"Arthritis Rheum"},{"key":"37_CR8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0272-5231(03)00134-5","volume":"25","author":"DA. White","year":"2004","unstructured":"White DA. Drug-induced pulmonary infection. Clin Chest Med. 2004;25:179\u201387.","journal-title":"Clin Chest Med"},{"key":"37_CR9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0049-0172(90)90060-S","volume":"20","author":"R Segal","year":"1990","unstructured":"Segal R, Yaron M, Tartakovsky B. Methotrexate: mechanism of action in rheumatoid arthritis. Semin Arthritis Rheum. 1990;20:190\u2013200.","journal-title":"Semin Arthritis Rheum"},{"key":"37_CR10","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10096-002-0758-5","volume":"21","author":"F Roblot","year":"2002","unstructured":"Roblot F, Godet C, Le Moal G, Garo B, Faouzi Souala M, Dary M, et al. Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients. Eur J Clin Microbiol Infect Dis. 2002;21:523\u201331.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"37_CR11","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4065\/71.1.5","volume":"71","author":"SH Yale","year":"1996","unstructured":"Yale SH, Limper AH. Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc. 1996;71:5\u201313.","journal-title":"Mayo Clin Proc"},{"issue":"Suppl 2","key":"37_CR12","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1093\/clinids\/17.Supplement_2.S416","volume":"17","author":"KA Sepkowitz","year":"1993","unstructured":"Sepkowitz KA. Pneumocystis carinii pneumonia in patients without AIDS. Clin Infect Dis. 1993;17(Suppl 2):S416\u201322.","journal-title":"Clin Infect Dis"},{"key":"37_CR13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ard.2007.072967","volume":"67","author":"T Takeuchi","year":"2007","unstructured":"Takeuchi T, Tatsuki Y, Nogami Y, Ishiguro N, Tanaka Y, Yamanaka H, et al. Post-marketing surveillance of the safety profile of infliximab in 5,000 Japanese patients with rheumatoid arthritis. Ann Rheum Dis. 2007;67:189\u201394.","journal-title":"Ann Rheum Dis"},{"key":"37_CR14","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3201\/eid0809.020096","volume":"8","author":"JR Stringer","year":"2002","unstructured":"Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis. 2002;8:891\u20136.","journal-title":"Emerg Infect Dis."},{"key":"37_CR15","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0140-6736(90)92008-6","volume":"336","author":"AE Wakefield","year":"1990","unstructured":"Wakefield AE, Pixley FJ, Banerji S, Sinclair K, Miller RF, Moxon ER, et al. Detection of Pneumocystis carinii with DNA amplification. Lancet. 1990;336:451\u20133.","journal-title":"Lancet"},{"key":"37_CR16","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1128\/JCM.39.11.3877-3882.2001","volume":"39","author":"RF Miller","year":"2001","unstructured":"Miller RF, Ambrose HE, Wakefield AE. Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia. J Clin Microbiol. 2001;39:3877\u201382.","journal-title":"J Clin Microbiol"},{"key":"37_CR17","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/thx.2004.039818","volume":"60","author":"RF Miller","year":"2005","unstructured":"Miller RF, Lindley AR, Copas A, Ambrose HE, Davies RJ, Wakefield AE. Genotypic variation in Pneumocystis jiroveci isolates in Britain. Thorax. 2005;60:679\u201382.","journal-title":"Thorax"},{"key":"37_CR18","first-page":"67","volume":"22","author":"A Ihata","year":"2002","unstructured":"Ihata A, Soga T, Takemura S, Fujita H. A case of Pneumocystis pneumonia associated with rheumatoid arthritis. Shizuoka Sekijyuji Byoin Kenkyuhou. 2002;22:67\u201371.","journal-title":"Shizuoka Sekijyuji Byoin Kenkyuhou"},{"key":"37_CR19","first-page":"74","volume":"36","author":"A Nakashima","year":"2005","unstructured":"Nakashima A, Toufuku Y, Ojima T. Seventy one year-old female patient with rheumatoid arthritis developed Pneumocystis carinii pneumonia mimicking methotrexate pneumonitis. J Chubu Rheum Assoc. 2005;36:74\u20135.","journal-title":"J Chubu Rheum Assoc"},{"key":"37_CR20","first-page":"30","volume":"25","author":"H Jojima","year":"2005","unstructured":"Jojima H, Naito M, Shiraishi M, Matsumoto T, Noritomi T, Hayashi H. Pneumocystis carinii pneumonia and perforation of the colon in a patient with rheumatoid arthritis receiving low dose methotrexate and glucocorticoid hormone. Kyushu J Rheumatol. 2005;25:30\u20134.","journal-title":"Kyushu J Rheumatol"},{"key":"37_CR21","first-page":"486","volume":"43","author":"Y Kawagishi","year":"2005","unstructured":"Kawagishi Y, Yamaguchi T, Matsui S, Narukawa M, Fujita T, Oda H, et al. A case of Pneumocystis pneumonia misidentified as methotrexate-induced pneumonitis. J Jap Respir Soc. 2005;43:486\u201390.","journal-title":"J Jap Respir Soc"},{"key":"37_CR22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/s10165-005-0443-5","volume":"16","author":"Y Kaneko","year":"2006","unstructured":"Kaneko Y, Suwa A, Ikeda Y, Hirakata M. Pneumocystis jiroveci pneumonia associated with low-dose methotrexate treatment for rheumatoid arthritis: report of two cases and review of the literature. Mod Rheumatol. 2006;16:36\u20138.","journal-title":"Mod Rheumatol."},{"key":"37_CR23","first-page":"26","volume":"37","author":"H Ohashi","year":"2006","unstructured":"Ohashi H, Izui Y, Kondo M, Saito M, Suzuki D. Pneumocystis carinii pneumonia treated with low dose methotrexate pulse therapy for rheumatoid arthritis: four cases report. J Chubu Rheum Assoc. 2006;37:26\u20137.","journal-title":"J Chubu Rheum Assoc"},{"key":"37_CR24","first-page":"551","volume":"36","author":"S Kitsuwa","year":"1996","unstructured":"Kitsuwa S, Matsunaga K, Kawai M, Tsuzi T, Kato K, Tani K, et al. Pancytopenia and Pneumocystis carinii pneumonia associated with low dose methotrexate pulse therapy for rheumatoid arthritis\u2013case report and review of literature. Ryumachi. 1996;36:551\u20138.","journal-title":"Ryumachi."},{"key":"37_CR25","first-page":"699","volume":"35","author":"Y Okuda","year":"1995","unstructured":"Okuda Y, Oyama T, Oyama H, Miyamoto T, Takasugi K. Pneumocystis carinii pneumonia associated with low dose methotrexate treatment for malignant rheumatoid arthritis. Ryumachi. 1995;35:699\u2013704.","journal-title":"Ryumachi."},{"key":"37_CR26","first-page":"78","volume":"38","author":"H Shoda","year":"2005","unstructured":"Shoda H, Inokuma S, Yajima N, Tanaka Y, Setoguchi K. Two cases of rheumatoid arthritis presenting lung injury during low dose methotrexate pulse therapy. Kanto Ryumachi. 2005;38:78\u201388.","journal-title":"Kanto Ryumachi"},{"key":"37_CR27","first-page":"575","volume":"53","author":"T Shimada","year":"2004","unstructured":"Shimada T, Nishimura Y, Funada Y, Takenaka K, Kobayashi K, Urata Y, et al. A case of pneumocystis carinii pneumonia associated with low dose methotrexate treatment for rheumatoid arthritis and trimethoprim-sulfamethoxazole induced pancytopenia. Arerugi. 2004;53:575\u201381.","journal-title":"Arerugi"},{"key":"37_CR28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.idc.2006.09.001","volume":"20","author":"LA Saketkoo","year":"2006","unstructured":"Saketkoo LA, Espinoza LR. Impact of biologic agents on infectious diseases. Infect Dis Clin North Am. 2006;20:931\u201361, viii.","journal-title":"Infect Dis Clin North Am"},{"key":"37_CR29","first-page":"197","volume":"3","author":"A Yasuoka","year":"1996","unstructured":"Yasuoka A, Tachikawa N, Shimada K, Kimura S, Oka S. (1\u2013>3) beta-d-glucan as a quantitative serological marker for Pneumocystis carinii pneumonia. Clin Diagn Lab Immunol. 1996;3:197\u20139.","journal-title":"Clin Diagn Lab Immunol"},{"key":"37_CR30","first-page":"3409","volume":"37","author":"A Sing","year":"1999","unstructured":"Sing A, Roggenkamp A, Autenrieth IB, Heesemann J. Pneumocystis carinii carriage in immunocompetent patients with primary pulmonary disorders as detected by single or nested PCR. J Clin Microbiol. 1999;37:3409\u201310.","journal-title":"J Clin Microbiol"},{"key":"37_CR31","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(96)91468-3","volume":"347","author":"EJ Calderon","year":"1996","unstructured":"Calderon EJ, Regordan C, Medrano FJ, Ollero M, Varela JM. Pneumocystis carinii infection in patients with chronic bronchial disease. Lancet. 1996;347:977.","journal-title":"Lancet"},{"key":"37_CR32","doi-asserted-by":"crossref","first-page":"591","DOI":"10.3109\/00365549709035900","volume":"29","author":"C Armbruster","year":"1997","unstructured":"Armbruster C, Hassl A, Kriwanek S. Pneumocystis carinii colonization in the absence of immunosuppression. Scand J Infect Dis. 1997;29:591\u20133.","journal-title":"Scand J Infect Dis"},{"key":"37_CR33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00002030-199903110-00020","volume":"13","author":"G Nevez","year":"1999","unstructured":"Nevez G, Raccurt C, Jounieaux V, Dei-Cas E, Mazars E. Pneumocystosis versus pulmonary Pneumocystis carinii colonization in HIV-negative and HIV-positive patients. AIDS. 1999;13:535\u20136.","journal-title":"AIDS."},{"key":"37_CR34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/thorax.58.7.594","volume":"58","author":"NA Maskell","year":"2003","unstructured":"Maskell NA, Waine DJ, Lindley A, Pepperell JC, Wakefield AE, Miller RF, et al. Asymptomatic carriage of Pneumocystis jiroveci in subjects undergoing bronchoscopy: a prospective study. Thorax. 2003;58:594\u20137.","journal-title":"Thorax"},{"key":"37_CR35","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1056\/NEJMc070728","volume":"357","author":"M Harigai","year":"2007","unstructured":"Harigai M, Koike R, Miyasaka N. Pneumocystis pneumonia associated with infliximab in Japan. N Engl J Med. 2007;357:1874\u20136.","journal-title":"N Engl J Med"},{"key":"37_CR36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/s10165-005-0454-2","volume":"16","author":"S Mori","year":"2006","unstructured":"Mori S, Imamura F, Kiyofuji C, Ito K, Koga Y, Honda I, et al. Pneumocystis jiroveci pneumonia in a patient with rheumatoid arthritis as a complication of treatment with infliximab, anti-tumor necrosis factor alpha neutralizing antibody. Mod Rheumatol. 2006;16:58\u201362.","journal-title":"Mod Rheumatol"},{"key":"37_CR37","doi-asserted-by":"crossref","first-page":"9203","DOI":"10.1073\/pnas.97.16.9203","volume":"97","author":"K Koetz","year":"2000","unstructured":"Koetz K, Bryl E, Spickschen K, O\u2019Fallon WM, Goronzy JJ, Weyand CM. T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci USA. 2000;97:9203\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"37_CR38","doi-asserted-by":"crossref","first-page":"14447","DOI":"10.1073\/pnas.95.24.14447","volume":"95","author":"UG Wagner","year":"1998","unstructured":"Wagner UG, Koetz K, Weyand CM, Goronzy JJ. Perturbation of the T cell repertoire in rheumatoid arthritis. Proc Natl Acad Sci USA. 1998;95:14447\u201352.","journal-title":"Proc Natl Acad Sci USA"},{"key":"37_CR39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1385\/IR:36:1:221","volume":"36","author":"AN. Vallejo","year":"2006","unstructured":"Vallejo AN. Age-dependent alterations of the T cell repertoire and functional diversity of T cells of the aged. Immunol Res. 2006;36:221\u20138.","journal-title":"Immunol Res"},{"key":"37_CR40","first-page":"465","volume":"45","author":"NTY Takayanagi","year":"2007","unstructured":"Takayanagi NTY, Tokunaga D, Miyahara Y, Yamaguchi S, Saito H, Ubukata M, et al. Pulmonary infections in patients with rheumatoid arthritis. J Jap Respir Soc. 2007;45:465\u201373.","journal-title":"J Jap Respir Soc"},{"key":"37_CR41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/s10165-006-0502-6","volume":"16","author":"N Iikuni","year":"2006","unstructured":"Iikuni N, Kitahama M, Ohta S, Okamoto H, Kamatani N, Nishinarita M. Evaluation of Pneumocystis pneumonia infection risk factors in patients with connective tissue disease. Mod Rheumatol. 2006;16:282\u20138.","journal-title":"Mod Rheumatol"},{"key":"37_CR42","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1164\/ajrccm.150.1.8025760","volume":"150","author":"GP LeMense","year":"1994","unstructured":"LeMense GP, Sahn SA. Opportunistic infection during treatment with low dose methotrexate. Am J Respir Crit Care Med. 1994;150:258\u201360.","journal-title":"Am J Respir Crit Care Med"},{"key":"37_CR43","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.21568","volume":"54","author":"F Wolfe","year":"2006","unstructured":"Wolfe F, Caplan L, Michaud K. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy. Arthritis Rheum. 2006;54:628\u201334.","journal-title":"Arthritis Rheum"},{"key":"37_CR44","doi-asserted-by":"crossref","unstructured":"Kirwan JR, Bijlsma JW, Boers M, Shea BJ. Effects of glucocorticoids on radiological progression in rheumatoid arthritis. Cochrane Database Syst Rev. 2007:CD006356.","DOI":"10.1002\/14651858.CD006356"},{"key":"37_CR45","unstructured":"Hashimoto H. Prophylaxis of Pneumocystis jiroveci pneumonia in autoimmune disease (in Japanese). Tokyo: Japanese Ministry of Health, Labor and Welfare Study Group on complication and treatment of immune disease. 2005:14\u20139."}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s10165-008-0037-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T16:24:55Z","timestamp":1646843095000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10165-008-0037-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,29]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1007\/s10165-008-0037-0","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,29]]}}}